Effects of hypoxia on the vasodilator activity of nifedipine and evidence of secondary pharmacological properties

European Journal of Pharmacology

Volumn 536, Issue 3, 2006, Pages 279-286

  Broadley, Kenneth J ^a   Penson, Peter E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Aorta; Hypoxia; Nifedipine; Noradrenaline; Phenylephrine

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; NIFEDIPINE; NORADRENALIN; PHENYLEPHRINE; POTASSIUM ION; PROPRANOLOL; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY TONE; ARTICLE; ATTENUATION; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING; VASODILATATION; ANIMAL; ANOXIA; DOSE RESPONSE; IN VITRO STUDY; PATHOPHYSIOLOGY; THORACIC AORTA; WISTAR RAT;

ANIMALS; ANOXIA; AORTA, THORACIC; CALCIUM CHANNEL BLOCKERS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NIFEDIPINE; NOREPINEPHRINE; PHENYLEPHRINE; PROPRANOLOL; RATS; RATS, WISTAR; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 33746206550     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.02.039     Document Type: Article

References (45)

1. Al-Sahli W., Ahmad H., Kheradmand F., Connolly C., and Docherty J.R. Effects of methylenedioxymethamphetamine on noradrenaline-evoked contractions of rat right ventricle and small mesenteric artery. Eur. J. Pharmacol. 422 (2001) 169-174
2. Angus J.A., Sarsero D., Fujiwara T., Molenaar P., and Xi Q. Quantitative analysis of vascular to cardiac selectivity of L- and T-type voltage-operated calcium channel antagonists in human tissues. Clin. Exp. Pharmacol. Physiol. 27 (2000) 1019-1021
3. Brawley L., Shaw A.M., and MacDonald A. Role of endothelium/nitric oxide in atypical β-adrenoceptor-mediated relaxation in rat isolated aorta. Eur. J. Pharmacol. 398 (2000) 285-296
4. Briley M., Cavero I., Langer S.Z., and Roach A.G. Evidence against β-adrenoceptor blocking activity of diltiazem, a drug with calcium antagonist properties. Br. J. Pharmacol. 69 (1980) 669-673
5. 1-purinoceptor-mediated vasodilatation and vasoconstriction in hypoxia. J. Auton. Pharmacol. 16 (1996) 363-366
6. Broadley K.J. Autonomic Pharmacology (1996), Taylor and Francis, London
7. Chen G., and Suzuki H. Some electrical properties of the endothelium-dependent hyperpolarization recorded from rat arterial smooth muscle cells. J. Physiol. (Lond.) 410 (1989) 91-106
8. Dargie H.J. Combination therapy with β-adrenoceptor blockers and calcium antagonists. Br. J. Clin. Pharmacol. 21 (1986) 155S-160S
9. Delaflotte S., Auguet M., Pirotzky E., Clostre F., and Braquet P. Effects of atrial natriuretic factor (ANF) on phenylephrine-triggered intra- and extracellular calcium dependent contraction in rat aorta. J. Auton. Pharmacol. 9 (1989) 211-218
10. 2+exchange activity in hearts subjected to hypoxia reoxygenation. Am. J. Physiol. - Heart Circ. Physiol. 253 (1987) H1026-H1034
11. Epstein M. Fixed-dose combination therapy with calcium antagonists. In: Epstein M. (Ed). Calcium Antagonists in Clinical Medicine (1998), Hanley and Belfus, Inc., Philadelphia 493-512
12. Feldman R.D., Park G.D., and Lai C.Y. The interaction of verapamil and norverapamil with β-adrenergic receptors. Circulation 72 (1985) 547-554
13. Ghisdal P., Vandenberg G., and Morel N. Rho-dependent kinase is involved in agonist-activated calcium entry in rat arteries. J. Physiol. (Lond.) 551 (2003) 855-867
14. 2+ entry and the regulation of smooth muscle tone. Trends Pharmacol. Sci. 19 (1998) 266-269
15. Godfraind T. Calcium exchange in vascular smooth muscle, action of noradrenaline and lanthanum. J. Physiol. (Lond.) 260 (1976) 21-35
16. Godfraind T. Actions of nifedipine on calcium fluxes and contraction of isolated rat arteries. J. Pharmacol. Exp. Ther. 224 (1983) 443-450
17. Godfraind T. Calcium channels in smooth muscle. Ann. N.Y. Acad. Sci. 522 (1988) 312-327
18. Godfraind T. Calcium antagonists and vasodilatation. Pharmacol. Ther. 64 (1994) 37-75
19. 45Ca fluxes in the rat isolated aorta. Br. J. Pharmacol. 77 (1982) 597-604
20. Godfraind T., Miller R., and Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol. Rev. 38 (1986) 321-416
21. Herrera G.M., and Walker B.R. Involvement of L-type calcium channels in hypoxic relaxation of vascular smooth muscles. J. Vasc. Res. 35 (1998) 265-273
22. Hoffman B.B., and Taylor P. Neurotransmission. In: Hardman J.G., Limbird L.E., and Gilman A.G. (Eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics (2001), McGraw-Hill, London 115-154
23. 2+ antagonists and neuroprotection from cerebral ischaemia. Eur. J. Pharmacol. 363 (1998) 1-15
24. Koch P., Wilffert B., Wilhelm D., and Peters T. An approach to differentiate between noradrenaline-elicited contractile processes in the rat isolated aorta. Naunyn-Schmiedeberg's Arch. Pharmacol. 342 (1990) 454-461
25. Kuchii M., Shibata S., and Mori J. Pharmacological nature of adrenergic innervation in rat aorta 1. Comp. Gen. Pharmacol. 4 (1973) 131-138
26. Liang J.-C., Yeh J.-L., Wang C.-S., Liou S.-F., Tsai C.-H., and Chen I.-J. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display α/β-adrenoceptor antagonist and long-acting antihypertensive activities. Bioorg. Med. Chem. 10 (2002) 719-730
27. 1D-adrenoceptor mediated contractions in rat aortic rings partially depolarised with KCl. Pharmacol. Res. 37 (1998) 437-454
28. Mecca T.E., and Love S.D. Comparative cardiovascular actions of clentiazem, diltiazem, verapamil, nifedipine, and nimodipine in isolated rabbit tissues. J. Cardiovasc. Pharmacol. 20 (1992) 678-682
29. Maling H.M., Fleisch J.H., and Saul W.F. Species differences in aortic responses to vasoactive amines: the effects of compound 48-80, cocaine, reserpine and 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 176 (1971) 672-683
30. Matheny J.L., Carrier G.O., and Ahlquist R.P. Role of neuronal and extraneuronal uptake in responses of rabbit iris dilator muscle to levarterenol and phenylephrine. J. Pharm. Sci. 66 (1977) 93-95
31. McDonald T.F., Pelzer S., Trautwein W., and Pelzer D.J. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol. Rev. 74 (1994) 365-507
32. McFadzean I., and Gibson A. The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle. Br. J. Pharmacol. 135 (2002) 1-13
33. Morel N., and Godfraind T. Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine. Br. J. Pharmacol. 102 (1991) 467-477
34. Nayler W.G. The potential for added benefits with β-blockers and calcium antagonists in treating cardiovascular disorders. Drugs 35 (1988) 1-8
35. 2 adrenoceptor-mediated responses in preparations of pulmonary artery and aorta from young and aged rats. J. Pharmacol. Exp. Ther. 228 (1984) 733-738
36. Orallo F. Regulation of cytosolic calcium levels in vascular smooth muscle. Pharmacol. Ther. 69 (1996) 153-171
37. Richardt G., Haass M., and Schomig A. Calcium antagonists and cardiac noradrenaline release in ischemia. J. Mol. Cell. Cardiol. 23 (1991) 269-277
38. 1-selective adrenoceptor antagonist, on voltage-dependent calcium channels in guinea-pig artery and vein. Br. J. Pharmacol. 115 (1995) 198-202
39. 2+ utilisation in signal transformation of alpha-1 adrenergic receptors. In: Ruffolo R.R.J. (Ed). The Alpha-1 Adrenergic Receptors (1987), Humana Press, Clifton, N.J. 113-187
40. Trendelenburg U. Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol. Rev. 18 (1966) 629-640
41. Triggle D.J. Mechanism of action of calcium channel antagonists. In: Epstein M. (Ed). Calcium Antagonists in Clinical Medicine (1997), Hanley and Belfus, Inc., Philadelphia 493-512
42. 2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur. J. Pharmacol. 69 (1981) 205-208
43. Vanhoutte P.M., Verbeuren T.J., and Van Nueten J.M. Effect of lidoflazine on systemic arteries and veins. Angiology 31 (1980) 581-593
44. Yeh J.L., Liou S.F., Liang J.C., Huang Y.C., Chiang L.C., Wu J.R., Lin Y.T., and Chen I.J. Vanidipinedilol: a vanilloid-based β-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities. J. Cardiovasc. Pharmacol. 35 (2000) 51-63
45. Yong M.S., and Chen P.-C. The effect of cocaine, reserpine, and 6-hydroxydopamine on the response of the perfused central artery of the rabbit ear to sympathomimetic amines. Can. J. Physiol. Pharmacol. 53 (1975) 38-46